Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Torex Retail Plc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

25 Jul 2007 Reuters Investment Profile 12 $20.00

Tissue Regenix Group PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

14 May 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Tissue Regenix Group PLC (TRX-LN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

24 May 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Tissue Regenix Group PLC

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

16 May 2016 Wright Reports 56 $75.00

Thomson Reuters Stock Report - Tissue Regenix Group PLC (TRX-LN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

15 May 2016 Thomson Reuters Stock Report 11 $25.00

Tissue Regenix Group PLC: Upgraded to Good

24 Mar 2016 Sadif Analytics Prime 3 $10.00

TISSUE REGENIX - PROGRESSING ON MULTIPLE FRONTS

Tissue Regenix’s (TRX’s) investment case is built on dCELL, a patented decellularised tissue scaffold. Wound care is a main d...

22 Mar 2016 Edison Investment Research 3 $10.00

Tissue Regenix (TRX.L): From development – into the commercial world

Tissue Regenix is no longer an R&D play. Its dCELL® technology enables production of ‘like-for-like’ tissue specific, structu...

26 Jan 2016 Hardman & Company 40 $414.00

Tissue Regenix Group PLC: Downgraded to Above Average

25 Jan 2016 Sadif Analytics Prime 3 $10.00

TISSUE REGENIX - STRONG PROSPECTS IN WOUND CARE

Tissue Regenix’s (TRX) investment case is built on dCELL, a patented decellularised tissue scaffold, whose regenerative prope...

22 Jan 2016 Edison Investment Research 16 $10.00